175 related articles for article (PubMed ID: 36871056)
1. Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding.
Islam MK; Amaya-Ramirez D; Maigret B; Devignes MD; Aridhi S; Smaïl-Tabbone M
Sci Rep; 2023 Mar; 13(1):3643. PubMed ID: 36871056
[TBL] [Abstract][Full Text] [Related]
2. Task-driven knowledge graph filtering improves prioritizing drugs for repurposing.
Ratajczak F; Joblin M; Ringsquandl M; Hildebrandt M
BMC Bioinformatics; 2022 Mar; 23(1):84. PubMed ID: 35246025
[TBL] [Abstract][Full Text] [Related]
3. Signaling repurposable drug combinations against COVID-19 by developing the heterogeneous deep herb-graph method.
Yang F; Zhang S; Pan W; Yao R; Zhang W; Zhang Y; Wang G; Zhang Q; Cheng Y; Dong J; Ruan C; Cui L; Wu H; Xue F
Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35514205
[TBL] [Abstract][Full Text] [Related]
4. Drug repurposing for COVID-19 via knowledge graph completion.
Zhang R; Hristovski D; Schutte D; Kastrin A; Fiszman M; Kilicoglu H
J Biomed Inform; 2021 Mar; 115():103696. PubMed ID: 33571675
[TBL] [Abstract][Full Text] [Related]
5. Using TransR to enhance drug repurposing knowledge graph for COVID-19 and its complications.
Zhao H; Li H; Liu Q; Dong G; Hou C; Li Y; Zhao Y
Methods; 2024 Jan; 221():82-90. PubMed ID: 38104883
[TBL] [Abstract][Full Text] [Related]
6. DrugRep-HeSiaGraph: when heterogenous siamese neural network meets knowledge graphs for drug repurposing.
Ghorbanali Z; Zare-Mirakabad F; Salehi N; Akbari M; Masoudi-Nejad A
BMC Bioinformatics; 2023 Oct; 24(1):374. PubMed ID: 37789314
[TBL] [Abstract][Full Text] [Related]
7. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
Su X; Hu L; You Z; Hu P; Wang L; Zhao B
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
[TBL] [Abstract][Full Text] [Related]
8. Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2.
Anwaar MU; Adnan F; Abro A; Khan RA; Rehman AU; Osama M; Rainville C; Kumar S; Sterner DE; Javed S; Jamal SB; Baig A; Shabbir MR; Ahsan W; Butt TR; Assir MZ
Comput Biol Med; 2022 Feb; 141():105049. PubMed ID: 34823857
[TBL] [Abstract][Full Text] [Related]
9. Knowledge Graph-Based Approaches to Drug Repurposing for COVID-19.
Al-Saleem J; Granet R; Ramakrishnan S; Ciancetta NA; Saveson C; Gessner C; Zhou Q
J Chem Inf Model; 2021 Aug; 61(8):4058-4067. PubMed ID: 34297570
[TBL] [Abstract][Full Text] [Related]
10. Knowledge-driven drug repurposing using a comprehensive drug knowledge graph.
Zhu Y; Che C; Jin B; Zhang N; Su C; Wang F
Health Informatics J; 2020 Dec; 26(4):2737-2750. PubMed ID: 32674665
[TBL] [Abstract][Full Text] [Related]
11. Potential Target Discovery and Drug Repurposing for Coronaviruses: Study Involving a Knowledge Graph-Based Approach.
Lou P; Fang A; Zhao W; Yao K; Yang Y; Hu J
J Med Internet Res; 2023 Oct; 25():e45225. PubMed ID: 37862061
[TBL] [Abstract][Full Text] [Related]
12. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.
Krämer A; Billaud JN; Tugendreich S; Shiffman D; Jones M; Green J
BMC Bioinformatics; 2021 May; 22(1):229. PubMed ID: 33941085
[TBL] [Abstract][Full Text] [Related]
13. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
14. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
Verma AK; Aggarwal R
Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
[TBL] [Abstract][Full Text] [Related]
15. Haste makes waste: A critical review of docking-based virtual screening in drug repurposing for SARS-CoV-2 main protease (M-pro) inhibition.
Macip G; Garcia-Segura P; Mestres-Truyol J; Saldivar-Espinoza B; Ojeda-Montes MJ; Gimeno A; Cereto-Massagué A; Garcia-Vallvé S; Pujadas G
Med Res Rev; 2022 Mar; 42(2):744-769. PubMed ID: 34697818
[TBL] [Abstract][Full Text] [Related]
16. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
[TBL] [Abstract][Full Text] [Related]
17. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.
Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
Arch Med Res; 2021 Jan; 52(1):38-47. PubMed ID: 32962867
[TBL] [Abstract][Full Text] [Related]
18. A network representation approach for COVID-19 drug recommendation.
Liu H; Lin H; Shen C; Yang L; Lin Y; Xu B; Yang Z; Wang J; Sun Y
Methods; 2022 Feb; 198():3-10. PubMed ID: 34562584
[TBL] [Abstract][Full Text] [Related]
19. Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics.
Piplani S; Singh P; Petrovsky N; Winkler DA
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835602
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns.
Mslati H; Gentile F; Perez C; Cherkasov A
J Chem Inf Model; 2021 Aug; 61(8):3771-3788. PubMed ID: 34313439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
